関連する実験動画
Updated: Sep 9, 2025

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
112.2K
KCTD10は,ユビキチン媒介のβ-カテニンの分解によって肺がんの転移と血管新生を抑制する
Zihao Yin1,2, Shengwen Long1,2, Hao Zhou1,2
1The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Science, Hunan Normal University, Changsha, China.
Frontiers in immunology
|August 28, 2025
まとめ
KCTD10は,β-キャテニンを分解し,PD- L1発現を減少させ,肺がんを抑制する. 肺がんの進行と転移に対して,抗PD-1療法と併用したKCTD10の過剰発現は,相乗効果を示している.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 研究
背景:
- 肺がんの発生率と死亡率は 世界的に高い.
- 肺がんを誘発する複雑な分子メカニズムは さらに解明する必要があります
- 肺がんの病原性におけるKCTD10の役割はほとんど不明である.
研究 の 目的:
- 肺がんにおけるKCTD10の機能を調査する.
- KCTD10が肺がんの進行に影響を与える分子メカニズムを決定する.
- 肺がんの潜在的治療標的としてKCTD10を研究する.
主な方法:
- 肺がん組織におけるKCTD10発現の定量分析
- 肺がんに対するKCTD10の影響を評価するためのin vitroおよびin vivo機能検査
- イムノプレシピテーション・マススペクトロメトリー (IP-MS),共免疫プレシピテーション (Co-IP),およびユビキチネーション測定法.
- 血管内皮細胞特異的な遺伝子ノックアウト研究
- METTL14とYTHDF2を用いたN6-メチラデノシン (m6A) 改変の分析
主要な成果:
- KCTD10の発現は肺がん組織で著しく低下しています.
- KCTD10の過剰発現は in vitro と in vivo で肺がんの進行を阻害する.
- KCTD10は,PD- L1をダウンレギュレーションして,K48結合ユビキチン化によってβ- カテニンの分解を促進する.
- KCTD10過剰発現と抗PD-1治療を併用すると,抗腫瘍効果が相乗効果を発揮する.
- 血管内皮細胞におけるKctd10ノックアウトは肺がんの転移と血管新生を促進する.
- METTL14媒介によるm6A変異は,KCTD10 mRNAの安定性を高める.
結論:
- KCTD10は,β-カテニンのシグナル伝達とPD- L1の発現を調節することによって,肺がんにおける腫瘍抑制剤として作用する.
- KCTD10は腫瘍の微小環境と血管新生を制御する上で重要な役割を果たします.
- KCTD10を標的とし,免疫療法と併用することで,肺がんに対する有望な治療法となる.
関連する概念動画
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Catenins
2.4K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.4K
Canonical Wnt Signaling Pathway
8.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Non-Canonical Wnt Signaling Pathways
7.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K

